Tourmaline Bio (NASDAQ:TRML) Now Covered by Analysts at Lifesci Capital
Lifesci Capital initiated coverage on shares of Tourmaline Bio (NASDAQ:TRML – Free Report) in a research note published on Monday,Benzinga reports. The firm issued an outperform rating and a $58.00 price target on the stock. TRML has been the topic of several other reports. BMO Capital Markets assumed coverage on Tourmaline Bio in a research […]
Lifesci Capital initiated coverage on shares of Tourmaline Bio (NASDAQ:TRML – Free Report) in a research note published on Monday,Benzinga reports. The firm issued an outperform rating and a $58.00 price target on the stock. TRML has been the topic of several other reports. BMO Capital Markets assumed coverage on Tourmaline Bio in a research […]
